KSR staff publications

2017

Ramaekers BLT, Wolff R, van Giessen A, Pouwels X, Fayter DLang S, et al. Trifluridine–tipiracil for previously treated metastatic colorectal cancer: an evidence review group perspective of a nice single technology appraisal [Epub ahead of print]. Pharmacoeconomics 2017. Full text.

 

Büyükkaramikli NC, Blommestein HM, Riemsma RArmstrong N, Clay FJ, Ross JWorthy G, Severens J, Kleijnen J, Al MJ. Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics 2017: [Epub ahead of print]. Full text.

 

Westwood M, Corro Ramos I, Lang S, Luyendijk M, Zaim R, Stirk L, Al M, Armstrong NKleijnen J. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis. Health Technology Assessment 2017;21(33):1-234. Full text.

 

Westwood MLang SArmstrong N, van Turenhout S, Cubiella J, Stirk L, Corro Ramos I, Luyendijk M, Ziam R, Kleijnen J, Fraser C. Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidance. BMC Med 2017;15:189. Full text.

 

Toth PP, Worthy G, Gandra SR, Sattar N, Bray S, Cheng LI, Bridges I, Worth GM, Dent R, Forbes CADeshpande SRoss JKleijnen J, Stroes ESG. Systematic review and network meta-analysis on the efficacy of evolocumab and other therapies for the management of lipid levels in hyperlipidemia. Journal of the American Heart Association 2017;6(10): pii: e005367. Full text.

 

Whiting PWolff R, Mallett S, Simera I, Savovic J. A proposed framework for developing quality assessment tools. Syst Rev 2017;6:204. Full text.

 

Ross JDe Kock SStirk LNoake CMisso KDuffy S. Systematic reviews assessed as high risk of bias due to avoidable failures in searching: analysis of a data set of critically appraised systematic reviews. Presented at the 9th International Clinical Librarian Conference (ICLC); 21-22nd Sep 2017; Leicester: UK.

 

Misso KRoss JNoake CDe Kock SStirk LDuffy S. Assessing systematic review search methods for risk of bias (RoB): how to spot common inadequacies and errors in the conduct and reporting of search strategies. Workshop. Presented at the 9th International Clinical Librarian Conference (ICLC); 21-22nd Sep 2017; Leicester: UK.

 

Toews I, Binder N, Wolff RF, Toprak G, von Elm E, Meerpohl JJ. Guidance in author instructions of hematology and oncology journals: a cross sectional and longitudinal study. PLoS One 2017;12(4):e0176489. Full text.

 

Ryder SLeadley RMArmstrong NWestwood Mde Kock S, Butt T, Jain M, Kleijnen J. The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review. Orphanet Journal of Rare Diseases 2017;12(1):79. Full text.

 

Riemsma R, Hagen S, Kirschner-Hermanns R, Norton C, Wijk H, Andersson KE, Chapple C, Spinks J, Wagg A, Hutt E, Misso KDeshpande SKleijnen J, Milsom I. Can incontinence be cured? A systematic review of cure rates. BMC Med 2017;15(1):63. Full text.

 

Professor Jos Kleijnen (Chair), Professor Paul Garner, Dr Phil Alderson, Ms Sally Crowe, Dr Jane Aubin, Professor John Cairns, Ms Kate Misso (report writer). Evaluation of NIHR investment in Cochrane infrastructure and systematic reviews: National Institute for Health Research, 2017. Full report.

 

Beckers LW, Schnackers ML, Janssen-Potten YJ, Kleijnen J, Steenbergen B. Feasibility and effect of home-based therapy programmes for children with cerebral palsy: a protocol for a systematic review. BMJ Open 2017;7(2):e013687. Full text.

 

Deshpande S, Quek RG, Forbes CAde Kock SKleijnen J, Gandra SR, Simpson RJ. A systematic review to assess the adherence and persistence with statins. Current Medical Research and Opinion 2017:1-23. [Epub ahead of print]. Abstract.